US Patent Issued to NCARDIA on Aug. 11 for "In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population" (Dutch Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,854, issued on Aug. 11, was assigned to NCARDIA B.V. (Leiden, Netherlands).

"In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population" was invented by Stefan Robbert Braam (Leiden, Netherlands) and Ana Catarina Martins Grandela (Leiden, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The current invention relates to a method of differentiation of human pluripotent stem cells into a human stem-cell derived population of cardiomyocytes. The method comprises the use of specific combination of steps and compounds to induce and/or promote differentiation. The method also comprises steps d...